Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oligonucleotide Array Sequence Analysis | 65 | 2015 | 3920 | 5.990 |
Why?
|
DNA Methylation | 37 | 2023 | 4282 | 2.780 |
Why?
|
Gene Expression Profiling | 50 | 2023 | 9410 | 2.460 |
Why?
|
Sequence Analysis, RNA | 14 | 2023 | 2011 | 2.290 |
Why?
|
Single-Cell Analysis | 9 | 2023 | 2183 | 2.070 |
Why?
|
Sequence Analysis, DNA | 19 | 2019 | 4801 | 1.810 |
Why?
|
Software | 30 | 2022 | 4434 | 1.770 |
Why?
|
Algorithms | 41 | 2023 | 13853 | 1.760 |
Why?
|
CpG Islands | 19 | 2019 | 1170 | 1.660 |
Why?
|
Base Composition | 5 | 2017 | 293 | 1.250 |
Why?
|
Models, Statistical | 14 | 2023 | 5100 | 1.250 |
Why?
|
Epigenesis, Genetic | 19 | 2023 | 3639 | 1.120 |
Why?
|
High-Throughput Nucleotide Sequencing | 13 | 2020 | 3585 | 1.120 |
Why?
|
Models, Genetic | 11 | 2016 | 3493 | 0.920 |
Why?
|
Cyclonic Storms | 2 | 2022 | 119 | 0.880 |
Why?
|
Genome | 9 | 2014 | 1803 | 0.850 |
Why?
|
Genomics | 19 | 2019 | 5692 | 0.830 |
Why?
|
Data Interpretation, Statistical | 12 | 2018 | 2714 | 0.750 |
Why?
|
Databases, Genetic | 9 | 2013 | 1780 | 0.710 |
Why?
|
Sequence Alignment | 4 | 2014 | 2257 | 0.710 |
Why?
|
DNA Probes | 5 | 2008 | 560 | 0.710 |
Why?
|
Computational Biology | 13 | 2020 | 3518 | 0.660 |
Why?
|
RNA | 7 | 2023 | 2747 | 0.630 |
Why?
|
Benchmarking | 3 | 2023 | 1038 | 0.620 |
Why?
|
Polymorphism, Single Nucleotide | 15 | 2014 | 15494 | 0.570 |
Why?
|
Gene Dosage | 3 | 2010 | 1251 | 0.550 |
Why?
|
Genome-Wide Association Study | 9 | 2017 | 12220 | 0.550 |
Why?
|
Genome, Human | 12 | 2017 | 4420 | 0.510 |
Why?
|
Artifacts | 4 | 2022 | 1903 | 0.510 |
Why?
|
Genotype | 9 | 2014 | 12946 | 0.500 |
Why?
|
Biometry | 3 | 2010 | 558 | 0.490 |
Why?
|
Cell Separation | 1 | 2019 | 1749 | 0.470 |
Why?
|
Genomic Structural Variation | 1 | 2014 | 65 | 0.470 |
Why?
|
DNA | 8 | 2017 | 7289 | 0.460 |
Why?
|
Preservation, Biological | 1 | 2011 | 25 | 0.410 |
Why?
|
Biotechnology | 2 | 2011 | 278 | 0.410 |
Why?
|
Nucleic Acid Hybridization | 7 | 2011 | 1374 | 0.400 |
Why?
|
Organ Specificity | 6 | 2021 | 2003 | 0.390 |
Why?
|
Stochastic Processes | 4 | 2009 | 344 | 0.390 |
Why?
|
Genetic Variation | 9 | 2017 | 6540 | 0.380 |
Why?
|
Normal Distribution | 4 | 2020 | 280 | 0.370 |
Why?
|
Epigenomics | 8 | 2023 | 902 | 0.330 |
Why?
|
Eukaryota | 1 | 2009 | 100 | 0.330 |
Why?
|
Alleles | 8 | 2014 | 6931 | 0.310 |
Why?
|
Oligonucleotides | 2 | 2010 | 572 | 0.300 |
Why?
|
Cluster Analysis | 7 | 2023 | 2713 | 0.300 |
Why?
|
Humans | 112 | 2024 | 742088 | 0.290 |
Why?
|
Colonic Neoplasms | 4 | 2014 | 2542 | 0.280 |
Why?
|
Transcription Factors | 5 | 2023 | 12164 | 0.270 |
Why?
|
Sensitivity and Specificity | 14 | 2016 | 14720 | 0.270 |
Why?
|
In Situ Hybridization, Fluorescence | 4 | 2020 | 2638 | 0.260 |
Why?
|
Bacteria | 3 | 2022 | 2102 | 0.260 |
Why?
|
Quality Control | 6 | 2011 | 841 | 0.260 |
Why?
|
Animals | 39 | 2024 | 168561 | 0.260 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5171 | 0.250 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2021 | 8425 | 0.250 |
Why?
|
Puerto Rico | 3 | 2022 | 356 | 0.250 |
Why?
|
Reproducibility of Results | 16 | 2021 | 19862 | 0.240 |
Why?
|
Poisson Distribution | 3 | 2021 | 512 | 0.240 |
Why?
|
Biological Evolution | 1 | 2009 | 1074 | 0.230 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2017 | 892 | 0.230 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2006 | 323 | 0.230 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13019 | 0.220 |
Why?
|
Saccharomyces cerevisiae | 8 | 2008 | 2749 | 0.220 |
Why?
|
DNA Copy Number Variations | 1 | 2011 | 1940 | 0.210 |
Why?
|
Oligonucleotide Probes | 4 | 2012 | 427 | 0.210 |
Why?
|
Promoter Regions, Genetic | 7 | 2017 | 5867 | 0.210 |
Why?
|
Chromatin | 4 | 2023 | 2917 | 0.210 |
Why?
|
Research Design | 3 | 2013 | 5979 | 0.200 |
Why?
|
Computer Simulation | 4 | 2019 | 6191 | 0.200 |
Why?
|
Peptide Library | 1 | 2022 | 350 | 0.200 |
Why?
|
Biostatistics | 3 | 2018 | 160 | 0.180 |
Why?
|
Information Storage and Retrieval | 3 | 2006 | 824 | 0.180 |
Why?
|
Aging | 3 | 2015 | 8626 | 0.180 |
Why?
|
Nervous System | 2 | 2019 | 553 | 0.170 |
Why?
|
Pharmacogenetics | 1 | 2023 | 676 | 0.170 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 2699 | 0.170 |
Why?
|
RNA, Messenger | 11 | 2022 | 13029 | 0.170 |
Why?
|
Gene Expression | 4 | 2022 | 7790 | 0.160 |
Why?
|
Transcription, Genetic | 6 | 2014 | 7721 | 0.160 |
Why?
|
Developed Countries | 1 | 2021 | 436 | 0.160 |
Why?
|
Mortality | 2 | 2021 | 2857 | 0.160 |
Why?
|
Mice | 18 | 2023 | 81045 | 0.160 |
Why?
|
Labor, Obstetric | 1 | 2021 | 333 | 0.160 |
Why?
|
User-Computer Interface | 4 | 2015 | 1426 | 0.150 |
Why?
|
Chromosomes | 1 | 2020 | 595 | 0.150 |
Why?
|
Gene Frequency | 3 | 2014 | 3587 | 0.150 |
Why?
|
Sequence Tagged Sites | 2 | 2008 | 94 | 0.150 |
Why?
|
Carcinoma | 1 | 2009 | 2374 | 0.150 |
Why?
|
Conserved Sequence | 2 | 2011 | 1202 | 0.140 |
Why?
|
HCT116 Cells | 3 | 2020 | 408 | 0.140 |
Why?
|
Vagina | 1 | 2021 | 825 | 0.140 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1659 | 0.130 |
Why?
|
Lysine | 2 | 2012 | 1008 | 0.130 |
Why?
|
Bayes Theorem | 4 | 2017 | 2303 | 0.130 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 212 | 0.130 |
Why?
|
DNA Restriction Enzymes | 2 | 2017 | 570 | 0.130 |
Why?
|
Carcinoma, Renal Cell | 2 | 2021 | 3123 | 0.130 |
Why?
|
Chromosome Mapping | 5 | 2017 | 4742 | 0.130 |
Why?
|
Th17 Cells | 1 | 2021 | 765 | 0.130 |
Why?
|
Gene Expression Regulation, Fungal | 2 | 2008 | 502 | 0.130 |
Why?
|
False Positive Reactions | 1 | 2017 | 981 | 0.130 |
Why?
|
Genes, Lethal | 4 | 2008 | 242 | 0.130 |
Why?
|
Cell Line, Tumor | 10 | 2022 | 16665 | 0.130 |
Why?
|
Fetal Movement | 2 | 2006 | 21 | 0.120 |
Why?
|
Homeostasis | 3 | 2021 | 3335 | 0.120 |
Why?
|
Uncertainty | 1 | 2019 | 725 | 0.120 |
Why?
|
CD4-Positive T-Lymphocytes | 3 | 2015 | 4379 | 0.120 |
Why?
|
Epidemiology | 1 | 2017 | 287 | 0.120 |
Why?
|
Sulfites | 2 | 2011 | 77 | 0.120 |
Why?
|
Circadian Rhythm | 3 | 2002 | 2623 | 0.120 |
Why?
|
Skin Aging | 1 | 2015 | 127 | 0.120 |
Why?
|
Autoimmunity | 1 | 2021 | 1348 | 0.120 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2017 | 730 | 0.120 |
Why?
|
Pathology, Molecular | 1 | 2017 | 325 | 0.120 |
Why?
|
Embryonic Stem Cells | 3 | 2010 | 1294 | 0.110 |
Why?
|
Sunlight | 1 | 2015 | 325 | 0.110 |
Why?
|
Human papillomavirus 18 | 1 | 2013 | 128 | 0.110 |
Why?
|
Tacrolimus Binding Proteins | 1 | 2013 | 194 | 0.110 |
Why?
|
Genes, Essential | 1 | 2014 | 182 | 0.110 |
Why?
|
Cell Line, Transformed | 1 | 2014 | 898 | 0.110 |
Why?
|
Neurogenesis | 1 | 2019 | 829 | 0.110 |
Why?
|
Intestines | 1 | 2021 | 1923 | 0.110 |
Why?
|
Sequence Deletion | 3 | 2012 | 1526 | 0.100 |
Why?
|
Cell Lineage | 4 | 2019 | 2504 | 0.100 |
Why?
|
Wavelet Analysis | 1 | 2012 | 57 | 0.100 |
Why?
|
NFI Transcription Factors | 1 | 2012 | 44 | 0.100 |
Why?
|
Disasters | 1 | 2018 | 510 | 0.100 |
Why?
|
Epidermis | 1 | 2015 | 527 | 0.100 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 2014 | 799 | 0.100 |
Why?
|
Methionine Sulfoxide Reductases | 1 | 2012 | 76 | 0.100 |
Why?
|
DNA Modification Methylases | 2 | 2010 | 206 | 0.100 |
Why?
|
Gastrointestinal Tract | 1 | 2017 | 814 | 0.100 |
Why?
|
Zinc Fingers | 1 | 2013 | 585 | 0.100 |
Why?
|
Gene Expression Regulation | 9 | 2016 | 12071 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2017 | 1728 | 0.100 |
Why?
|
Cell Line | 8 | 2017 | 15994 | 0.100 |
Why?
|
Histone Deacetylase 1 | 1 | 2012 | 137 | 0.100 |
Why?
|
DNA, Neoplasm | 3 | 2011 | 1758 | 0.100 |
Why?
|
Pandemics | 2 | 2022 | 8328 | 0.100 |
Why?
|
p300-CBP Transcription Factors | 1 | 2012 | 147 | 0.100 |
Why?
|
Internet | 5 | 2013 | 3062 | 0.100 |
Why?
|
Binding Sites | 2 | 2017 | 6115 | 0.100 |
Why?
|
Freezing | 1 | 2011 | 303 | 0.100 |
Why?
|
Species Specificity | 4 | 2009 | 2479 | 0.100 |
Why?
|
DNA, Intergenic | 1 | 2011 | 107 | 0.100 |
Why?
|
Gene Knockout Techniques | 1 | 2014 | 808 | 0.090 |
Why?
|
Spleen | 2 | 2021 | 2359 | 0.090 |
Why?
|
Reference Values | 2 | 2016 | 4982 | 0.090 |
Why?
|
Base Sequence | 6 | 2014 | 12797 | 0.090 |
Why?
|
Human Genome Project | 1 | 2010 | 192 | 0.090 |
Why?
|
Drosophila melanogaster | 1 | 2019 | 1704 | 0.090 |
Why?
|
Genomic Imprinting | 2 | 2008 | 331 | 0.090 |
Why?
|
Markov Chains | 2 | 2010 | 969 | 0.090 |
Why?
|
Protein Methyltransferases | 1 | 2009 | 55 | 0.090 |
Why?
|
Genetic Heterogeneity | 1 | 2013 | 732 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1167 | 0.080 |
Why?
|
Chromosomes, Human | 1 | 2011 | 457 | 0.080 |
Why?
|
Histones | 3 | 2009 | 2597 | 0.080 |
Why?
|
Neoplasms | 7 | 2017 | 21596 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 944 | 0.080 |
Why?
|
Euchromatin | 1 | 2008 | 56 | 0.080 |
Why?
|
Body Temperature | 2 | 2002 | 776 | 0.080 |
Why?
|
Stem Cells | 1 | 2021 | 3563 | 0.080 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2012 | 608 | 0.080 |
Why?
|
Virus Latency | 1 | 2011 | 356 | 0.080 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2022 | 947 | 0.080 |
Why?
|
Probability | 1 | 2014 | 2502 | 0.080 |
Why?
|
Azacitidine | 1 | 2010 | 347 | 0.080 |
Why?
|
Analysis of Variance | 4 | 2012 | 6365 | 0.080 |
Why?
|
Myosin Type II | 1 | 2008 | 68 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2019 | 3617 | 0.080 |
Why?
|
Sample Size | 1 | 2011 | 844 | 0.080 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2010 | 282 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4438 | 0.070 |
Why?
|
Alternative Splicing | 1 | 2012 | 1118 | 0.070 |
Why?
|
Databases, Factual | 3 | 2011 | 7716 | 0.070 |
Why?
|
Saliva | 1 | 2011 | 805 | 0.070 |
Why?
|
Acetate-CoA Ligase | 1 | 2006 | 11 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2010 | 981 | 0.070 |
Why?
|
Reference Standards | 2 | 2008 | 1020 | 0.070 |
Why?
|
Models, Theoretical | 2 | 2012 | 3584 | 0.070 |
Why?
|
Coenzyme A Ligases | 1 | 2006 | 43 | 0.070 |
Why?
|
Cell Physiological Phenomena | 1 | 2008 | 154 | 0.070 |
Why?
|
Exons | 1 | 2012 | 2431 | 0.070 |
Why?
|
Maternal-Fetal Relations | 1 | 2006 | 25 | 0.070 |
Why?
|
Early Detection of Cancer | 1 | 2020 | 3070 | 0.070 |
Why?
|
MicroRNAs | 1 | 2022 | 3731 | 0.070 |
Why?
|
Heterochromatin | 1 | 2008 | 295 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2024 | 5249 | 0.070 |
Why?
|
Genes, Fungal | 2 | 2005 | 455 | 0.070 |
Why?
|
Sarcoma | 1 | 2017 | 1895 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2022 | 4823 | 0.070 |
Why?
|
Microdissection | 1 | 2006 | 152 | 0.070 |
Why?
|
Mouth Neoplasms | 1 | 2011 | 601 | 0.070 |
Why?
|
Genome, Fungal | 4 | 2008 | 204 | 0.070 |
Why?
|
Gene Silencing | 2 | 2010 | 1538 | 0.070 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2011 | 475 | 0.070 |
Why?
|
Models, Biological | 3 | 2015 | 9581 | 0.070 |
Why?
|
District of Columbia | 1 | 2005 | 157 | 0.060 |
Why?
|
Gene Library | 3 | 2015 | 1076 | 0.060 |
Why?
|
Giant Cells | 1 | 2005 | 187 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1599 | 0.060 |
Why?
|
Gestational Age | 2 | 2012 | 3490 | 0.060 |
Why?
|
Baltimore | 1 | 2005 | 231 | 0.060 |
Why?
|
Registries | 1 | 2020 | 8077 | 0.060 |
Why?
|
Nerve Tissue Proteins | 3 | 2012 | 4465 | 0.060 |
Why?
|
Heart Rate | 3 | 2006 | 4091 | 0.060 |
Why?
|
Clone Cells | 2 | 2021 | 1692 | 0.060 |
Why?
|
Behavior, Animal | 1 | 2012 | 1882 | 0.060 |
Why?
|
Genes, MHC Class II | 1 | 2005 | 458 | 0.060 |
Why?
|
Kidney Neoplasms | 1 | 2021 | 4229 | 0.060 |
Why?
|
Leydig Cells | 1 | 2004 | 56 | 0.060 |
Why?
|
Fibroblasts | 2 | 2017 | 4143 | 0.060 |
Why?
|
Myocardial Ischemia | 2 | 2005 | 2145 | 0.060 |
Why?
|
Artificial Intelligence | 2 | 2008 | 2187 | 0.060 |
Why?
|
Chromatids | 1 | 2004 | 63 | 0.060 |
Why?
|
Observation | 1 | 2006 | 312 | 0.060 |
Why?
|
Prostatic Neoplasms | 3 | 2013 | 11039 | 0.060 |
Why?
|
Databases, Bibliographic | 1 | 2004 | 128 | 0.060 |
Why?
|
Saccharomycetales | 1 | 2004 | 67 | 0.060 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2006 | 371 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2015 | 2956 | 0.060 |
Why?
|
Cell Nucleus | 2 | 2018 | 2968 | 0.060 |
Why?
|
Liver | 3 | 2010 | 7470 | 0.060 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2005 | 365 | 0.060 |
Why?
|
Mice, Inbred AKR | 1 | 2002 | 107 | 0.060 |
Why?
|
Cytosol | 1 | 2006 | 901 | 0.060 |
Why?
|
Prefrontal Cortex | 1 | 2013 | 2146 | 0.050 |
Why?
|
DNA Transposable Elements | 1 | 2006 | 748 | 0.050 |
Why?
|
Cardiomyopathies | 2 | 2005 | 1912 | 0.050 |
Why?
|
Prostate | 1 | 2011 | 1764 | 0.050 |
Why?
|
Disease Susceptibility | 1 | 2009 | 1780 | 0.050 |
Why?
|
S Phase | 1 | 2004 | 423 | 0.050 |
Why?
|
DNA, Complementary | 1 | 2006 | 2049 | 0.050 |
Why?
|
Colon | 1 | 2010 | 1773 | 0.050 |
Why?
|
Sign Language | 1 | 2001 | 11 | 0.050 |
Why?
|
Systems Biology | 1 | 2006 | 469 | 0.050 |
Why?
|
Lung Diseases | 2 | 2010 | 1884 | 0.050 |
Why?
|
Neoplasm Metastasis | 2 | 2013 | 4839 | 0.050 |
Why?
|
Activity Cycles | 1 | 2002 | 51 | 0.050 |
Why?
|
Down Syndrome | 1 | 2010 | 880 | 0.050 |
Why?
|
Liver Diseases | 1 | 2010 | 1252 | 0.050 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2003 | 503 | 0.050 |
Why?
|
Heart Rate, Fetal | 1 | 2001 | 75 | 0.050 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2417 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 383 | 0.050 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2013 | 2011 | 0.050 |
Why?
|
Laboratories | 1 | 2005 | 461 | 0.050 |
Why?
|
Caloric Restriction | 1 | 2004 | 302 | 0.050 |
Why?
|
Hematopoietic Stem Cells | 2 | 2010 | 3381 | 0.050 |
Why?
|
Hypothermia | 1 | 2002 | 189 | 0.050 |
Why?
|
Neuroglia | 2 | 2019 | 925 | 0.050 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2010 | 1515 | 0.050 |
Why?
|
Pseudomonas Infections | 1 | 2005 | 608 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2010 | 2066 | 0.050 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5133 | 0.050 |
Why?
|
Hippocampus | 1 | 2013 | 3661 | 0.050 |
Why?
|
Bradycardia | 1 | 2002 | 305 | 0.050 |
Why?
|
Female | 23 | 2022 | 379592 | 0.050 |
Why?
|
Microarray Analysis | 1 | 2004 | 766 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2020 | 6754 | 0.050 |
Why?
|
Receptors, Interleukin | 1 | 2021 | 245 | 0.050 |
Why?
|
Lactobacillus | 1 | 2021 | 189 | 0.050 |
Why?
|
Databases, Nucleic Acid | 2 | 2012 | 211 | 0.050 |
Why?
|
Fetal Development | 1 | 2006 | 767 | 0.050 |
Why?
|
Male | 20 | 2021 | 349538 | 0.050 |
Why?
|
Verbal Behavior | 1 | 2001 | 339 | 0.050 |
Why?
|
Fetus | 2 | 2006 | 1879 | 0.050 |
Why?
|
Cardiomegaly | 1 | 2003 | 619 | 0.050 |
Why?
|
Mutation | 6 | 2024 | 29717 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2003 | 916 | 0.050 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2015 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2010 | 1431 | 0.040 |
Why?
|
Republic of Korea | 1 | 2021 | 538 | 0.040 |
Why?
|
Sequence Homology, Nucleic Acid | 2 | 2014 | 1086 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 3800 | 0.040 |
Why?
|
Cause of Death | 2 | 2020 | 3571 | 0.040 |
Why?
|
Biodiversity | 1 | 2021 | 341 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 867 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 713 | 0.040 |
Why?
|
Viral Proteins | 1 | 2006 | 1899 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2003 | 1213 | 0.040 |
Why?
|
Polymerase Chain Reaction | 5 | 2005 | 6171 | 0.040 |
Why?
|
Motor Activity | 3 | 2006 | 2714 | 0.040 |
Why?
|
Drosophila | 1 | 2006 | 1484 | 0.040 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2021 | 902 | 0.040 |
Why?
|
United States | 3 | 2022 | 69693 | 0.040 |
Why?
|
Death | 1 | 2002 | 675 | 0.040 |
Why?
|
Myocarditis | 1 | 2005 | 770 | 0.040 |
Why?
|
Molecular Dynamics Simulation | 1 | 2020 | 413 | 0.040 |
Why?
|
Cell Differentiation | 3 | 2010 | 11470 | 0.040 |
Why?
|
HeLa Cells | 2 | 2018 | 3127 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 21821 | 0.040 |
Why?
|
Asthma | 2 | 2007 | 5955 | 0.040 |
Why?
|
Population Density | 1 | 2017 | 194 | 0.040 |
Why?
|
Statistics, Nonparametric | 1 | 2003 | 2885 | 0.040 |
Why?
|
Cell Division | 2 | 2020 | 4564 | 0.040 |
Why?
|
Pancreas | 1 | 2024 | 1684 | 0.040 |
Why?
|
Genetic Complementation Test | 1 | 2017 | 561 | 0.040 |
Why?
|
Uganda | 1 | 2021 | 1239 | 0.040 |
Why?
|
Phosphorylation | 3 | 2015 | 8436 | 0.040 |
Why?
|
Cystic Fibrosis | 1 | 2005 | 1178 | 0.040 |
Why?
|
Aged | 9 | 2021 | 162944 | 0.040 |
Why?
|
Acetylation | 2 | 2012 | 1085 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1683 | 0.030 |
Why?
|
RNA, Fungal | 2 | 2008 | 164 | 0.030 |
Why?
|
Lymphocytes | 2 | 2017 | 2614 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3293 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2023 | 1190 | 0.030 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2021 | 834 | 0.030 |
Why?
|
Phenotype | 2 | 2012 | 16331 | 0.030 |
Why?
|
Population Dynamics | 1 | 2017 | 301 | 0.030 |
Why?
|
Interleukin-17 | 1 | 2021 | 900 | 0.030 |
Why?
|
K562 Cells | 1 | 2017 | 632 | 0.030 |
Why?
|
Central Nervous System | 1 | 2003 | 1354 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2011 | 4029 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1038 | 0.030 |
Why?
|
Histone-Lysine N-Methyltransferase | 2 | 2010 | 670 | 0.030 |
Why?
|
Protein Structure, Tertiary | 2 | 2013 | 3847 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2022 | 1983 | 0.030 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2003 | 2231 | 0.030 |
Why?
|
Programming Languages | 1 | 2015 | 134 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2459 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3339 | 0.030 |
Why?
|
RNA Editing | 1 | 2015 | 148 | 0.030 |
Why?
|
Depressive Disorder, Major | 1 | 2012 | 4628 | 0.030 |
Why?
|
Aged, 80 and over | 6 | 2021 | 57683 | 0.030 |
Why?
|
Molecular Sequence Annotation | 1 | 2016 | 527 | 0.030 |
Why?
|
Adult | 12 | 2021 | 213712 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2023 | 1860 | 0.030 |
Why?
|
Adaptation, Biological | 1 | 2014 | 152 | 0.030 |
Why?
|
Air Pollution | 1 | 2007 | 2284 | 0.030 |
Why?
|
HIV-1 | 1 | 2011 | 6934 | 0.030 |
Why?
|
Pregnancy | 3 | 2021 | 29087 | 0.030 |
Why?
|
HL-60 Cells | 1 | 2014 | 365 | 0.030 |
Why?
|
RNA, Ribosomal | 1 | 2014 | 246 | 0.030 |
Why?
|
Chile | 1 | 2013 | 237 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3199 | 0.030 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2017 | 628 | 0.030 |
Why?
|
Bipolar Disorder | 1 | 2010 | 5024 | 0.030 |
Why?
|
Escherichia coli K12 | 1 | 2012 | 35 | 0.030 |
Why?
|
Bees | 1 | 2012 | 43 | 0.030 |
Why?
|
Body Mass Index | 1 | 2010 | 12695 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5948 | 0.030 |
Why?
|
Public Health | 1 | 2006 | 2594 | 0.030 |
Why?
|
Rats | 5 | 2010 | 24265 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2524 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2900 | 0.030 |
Why?
|
Feces | 1 | 2017 | 1394 | 0.030 |
Why?
|
Longitudinal Studies | 2 | 2008 | 13921 | 0.030 |
Why?
|
Phylogeny | 1 | 2019 | 2797 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2008 | 10163 | 0.020 |
Why?
|
Biocatalysis | 1 | 2012 | 167 | 0.020 |
Why?
|
Guidelines as Topic | 2 | 2010 | 1402 | 0.020 |
Why?
|
Lung | 3 | 2024 | 9826 | 0.020 |
Why?
|
Prognosis | 2 | 2012 | 29010 | 0.020 |
Why?
|
Insect Proteins | 1 | 2012 | 258 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2003 | 3691 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1337 | 0.020 |
Why?
|
Pattern Recognition, Automated | 2 | 2008 | 996 | 0.020 |
Why?
|
Nuclear Transfer Techniques | 1 | 2010 | 64 | 0.020 |
Why?
|
Time Factors | 6 | 2010 | 40054 | 0.020 |
Why?
|
Child, Preschool | 3 | 2021 | 40955 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1707 | 0.020 |
Why?
|
Biomedical Research | 1 | 2006 | 3306 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2842 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2010 | 447 | 0.020 |
Why?
|
Autopsy | 1 | 2013 | 1006 | 0.020 |
Why?
|
Head and Neck Neoplasms | 1 | 2003 | 2712 | 0.020 |
Why?
|
Dogs | 2 | 2005 | 3910 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2012 | 699 | 0.020 |
Why?
|
Cell Movement | 1 | 2021 | 5212 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3455 | 0.020 |
Why?
|
Infant, Newborn | 3 | 2021 | 25575 | 0.020 |
Why?
|
Molecular Sequence Data | 3 | 2008 | 18112 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2011 | 2915 | 0.020 |
Why?
|
Virus Integration | 1 | 2011 | 297 | 0.020 |
Why?
|
Color | 1 | 2010 | 306 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2011 | 442 | 0.020 |
Why?
|
Gene Deletion | 2 | 2008 | 2751 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3564 | 0.020 |
Why?
|
Data Mining | 1 | 2013 | 537 | 0.020 |
Why?
|
Mouth | 1 | 2011 | 373 | 0.020 |
Why?
|
Utah | 1 | 2008 | 126 | 0.020 |
Why?
|
Area Under Curve | 1 | 2012 | 1653 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2019 | 5975 | 0.020 |
Why?
|
Arabidopsis | 1 | 2012 | 459 | 0.020 |
Why?
|
Iceland | 1 | 2008 | 183 | 0.020 |
Why?
|
Magnetics | 1 | 2011 | 609 | 0.020 |
Why?
|
Cells, Cultured | 3 | 2011 | 19223 | 0.020 |
Why?
|
Aminopeptidases | 1 | 2008 | 88 | 0.020 |
Why?
|
Cohort Studies | 3 | 2020 | 40450 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2012 | 1802 | 0.020 |
Why?
|
Middle Aged | 8 | 2021 | 213127 | 0.020 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2008 | 1884 | 0.020 |
Why?
|
Receptors, Steroid | 1 | 2008 | 155 | 0.020 |
Why?
|
Adolescent | 4 | 2021 | 85649 | 0.020 |
Why?
|
Aminoglycosides | 1 | 2008 | 161 | 0.020 |
Why?
|
Breast Neoplasms | 3 | 2012 | 20774 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10392 | 0.020 |
Why?
|
Child | 4 | 2021 | 77478 | 0.020 |
Why?
|
Young Adult | 3 | 2021 | 56350 | 0.020 |
Why?
|
Carbohydrate Metabolism | 1 | 2008 | 264 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2003 | 9941 | 0.020 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2008 | 338 | 0.020 |
Why?
|
Electroencephalography | 1 | 2001 | 6142 | 0.020 |
Why?
|
Carbocyanines | 1 | 2006 | 174 | 0.020 |
Why?
|
Fetal Monitoring | 1 | 2006 | 70 | 0.020 |
Why?
|
Cardiotocography | 1 | 2006 | 23 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5655 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2011 | 1081 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12773 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2008 | 405 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2011 | 1184 | 0.020 |
Why?
|
Ribosomal Proteins | 1 | 2008 | 360 | 0.020 |
Why?
|
Myeloid Cells | 1 | 2010 | 804 | 0.020 |
Why?
|
Retroelements | 1 | 2006 | 164 | 0.020 |
Why?
|
Rats, Inbred WF | 1 | 2005 | 140 | 0.020 |
Why?
|
Nicotinic Acids | 1 | 2005 | 31 | 0.020 |
Why?
|
Galactose | 1 | 2006 | 306 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4414 | 0.020 |
Why?
|
Retinoid X Receptors | 1 | 2005 | 93 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2001 | 5705 | 0.020 |
Why?
|
DNA, Bacterial | 1 | 2010 | 1465 | 0.020 |
Why?
|
Tetrahydronaphthalenes | 1 | 2005 | 89 | 0.020 |
Why?
|
Expressed Sequence Tags | 1 | 2005 | 255 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2008 | 1574 | 0.020 |
Why?
|
Sex Characteristics | 2 | 2006 | 2585 | 0.020 |
Why?
|
Infant | 2 | 2021 | 35070 | 0.020 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9639 | 0.020 |
Why?
|
Gene Rearrangement | 1 | 2010 | 1179 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2005 | 462 | 0.020 |
Why?
|
Drug Resistance, Multiple | 1 | 2005 | 252 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 21719 | 0.020 |
Why?
|
Histone Acetyltransferases | 1 | 2006 | 336 | 0.020 |
Why?
|
Galvanic Skin Response | 1 | 2006 | 349 | 0.020 |
Why?
|
Age Factors | 1 | 2021 | 18355 | 0.010 |
Why?
|
Carboxylesterase | 1 | 2004 | 31 | 0.010 |
Why?
|
Rats, Inbred BN | 1 | 2004 | 235 | 0.010 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 1655 | 0.010 |
Why?
|
Metaphase | 1 | 2004 | 151 | 0.010 |
Why?
|
Electrophoresis | 1 | 2004 | 240 | 0.010 |
Why?
|
Mutagenesis, Insertional | 1 | 2006 | 655 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9305 | 0.010 |
Why?
|
Chromosomes, Fungal | 1 | 2004 | 111 | 0.010 |
Why?
|
Metabolome | 1 | 2010 | 881 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2964 | 0.010 |
Why?
|
Pluripotent Stem Cells | 1 | 2010 | 795 | 0.010 |
Why?
|
Peru | 1 | 2006 | 881 | 0.010 |
Why?
|
Thailand | 1 | 2004 | 296 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2890 | 0.010 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2003 | 170 | 0.010 |
Why?
|
Coloring Agents | 1 | 2005 | 565 | 0.010 |
Why?
|
Genetic Techniques | 1 | 2005 | 435 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1158 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2699 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2003 | 24913 | 0.010 |
Why?
|
Tandem Mass Spectrometry | 1 | 2008 | 1157 | 0.010 |
Why?
|
Proteomics | 1 | 2015 | 3618 | 0.010 |
Why?
|
Neuroblastoma | 1 | 2010 | 1225 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2007 | 12242 | 0.010 |
Why?
|
Signal Transduction | 3 | 2015 | 23387 | 0.010 |
Why?
|
Epilepsy, Complex Partial | 1 | 2001 | 62 | 0.010 |
Why?
|
Metabolomics | 1 | 2010 | 1467 | 0.010 |
Why?
|
Computer Graphics | 1 | 2004 | 360 | 0.010 |
Why?
|
Predictive Value of Tests | 2 | 2010 | 15056 | 0.010 |
Why?
|
Multigene Family | 1 | 2005 | 1102 | 0.010 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2003 | 534 | 0.010 |
Why?
|
Geography | 1 | 2004 | 669 | 0.010 |
Why?
|
Endothelium | 1 | 2004 | 778 | 0.010 |
Why?
|
Heterozygote | 1 | 2008 | 2790 | 0.010 |
Why?
|
Molecular Probes | 1 | 2003 | 316 | 0.010 |
Why?
|
Parity | 1 | 2004 | 929 | 0.010 |
Why?
|
Heart Failure | 1 | 2005 | 10856 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2001 | 438 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 2006 | 3133 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1989 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2002 | 964 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 2005 | 1741 | 0.010 |
Why?
|
Pedigree | 1 | 2008 | 4646 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2003 | 689 | 0.010 |
Why?
|
Down-Regulation | 1 | 2008 | 3001 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 815 | 0.010 |
Why?
|
Nonlinear Dynamics | 1 | 2003 | 502 | 0.010 |
Why?
|
Genes | 1 | 2004 | 1892 | 0.010 |
Why?
|
Blotting, Western | 1 | 2008 | 5180 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 2003 | 1866 | 0.010 |
Why?
|
Fungal Proteins | 1 | 2004 | 912 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2006 | 2372 | 0.010 |
Why?
|
Protein Binding | 1 | 2012 | 9387 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2004 | 1159 | 0.010 |
Why?
|
Drug Hypersensitivity | 1 | 2008 | 883 | 0.010 |
Why?
|
Prenatal Diagnosis | 1 | 2006 | 1232 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4187 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2011 | 3678 | 0.010 |
Why?
|
Cytoskeletal Proteins | 1 | 2004 | 1363 | 0.010 |
Why?
|
Disease Models, Animal | 2 | 2010 | 18006 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4211 | 0.010 |
Why?
|
Isoenzymes | 1 | 2003 | 1725 | 0.010 |
Why?
|
Arousal | 1 | 2004 | 1165 | 0.010 |
Why?
|
Equipment Design | 1 | 2006 | 3582 | 0.010 |
Why?
|
Escherichia coli | 1 | 2010 | 4214 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2005 | 1915 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 4751 | 0.010 |
Why?
|
Survival Analysis | 1 | 2010 | 10248 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2005 | 2006 | 0.010 |
Why?
|
DNA Replication | 1 | 2004 | 1397 | 0.010 |
Why?
|
Lung Transplantation | 1 | 2005 | 1155 | 0.010 |
Why?
|
Fetal Diseases | 1 | 2001 | 903 | 0.010 |
Why?
|
Regression Analysis | 1 | 2006 | 6452 | 0.010 |
Why?
|
Evoked Potentials | 1 | 2001 | 1057 | 0.010 |
Why?
|
ROC Curve | 1 | 2003 | 3528 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 2015 | 5662 | 0.010 |
Why?
|
Mothers | 1 | 2006 | 2163 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7873 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11363 | 0.010 |
Why?
|
Heart-Assist Devices | 1 | 2005 | 1194 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 5062 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2008 | 5019 | 0.010 |
Why?
|
Glucose | 1 | 2006 | 4391 | 0.010 |
Why?
|
DNA Repair | 1 | 2004 | 2042 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2005 | 5519 | 0.010 |
Why?
|
Neurons | 1 | 2013 | 9325 | 0.010 |
Why?
|
Brain | 2 | 2012 | 26343 | 0.010 |
Why?
|
Forecasting | 1 | 2002 | 2948 | 0.010 |
Why?
|
Biopsy | 1 | 2005 | 6756 | 0.010 |
Why?
|
Mitochondria | 1 | 2006 | 3520 | 0.010 |
Why?
|
Testosterone | 1 | 2004 | 2401 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2005 | 3801 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2010 | 5169 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2004 | 3444 | 0.010 |
Why?
|
Infant, Premature | 1 | 2001 | 2041 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2014 | 17400 | 0.010 |
Why?
|
Body Weight | 1 | 2002 | 4664 | 0.010 |
Why?
|
Risk | 1 | 2003 | 9679 | 0.010 |
Why?
|
Anxiety | 1 | 2004 | 4279 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12958 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2004 | 4229 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5851 | 0.010 |
Why?
|
Disease Progression | 1 | 2005 | 13256 | 0.010 |
Why?
|
Imaging, Three-Dimensional | 1 | 2001 | 4029 | 0.000 |
Why?
|
Risk Factors | 2 | 2007 | 72145 | 0.000 |
Why?
|
Brain Mapping | 1 | 2001 | 6669 | 0.000 |
Why?
|
Incidence | 1 | 2004 | 20928 | 0.000 |
Why?
|
Depression | 1 | 2004 | 7733 | 0.000 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2001 | 8925 | 0.000 |
Why?
|